Capricor Therapeutics Inc (CAPR)

[dia76ca]

Submission Complete! Oral Presentation at Conference March 11 ! And then...
1. Phase 3 data article published in leading medical journal
2. FDA announcing new PDUFA date
3. Deramiocel FDA approval
4. Deramiocel European + ROW PARTNERSHIP
(with NS or Big Pharma ?)
5. More NS milestones for Deramiocel in Japan
6. Becker will advance (approval or trial)
7. StealthX Covid vaccine results (NIAID funded)
8. StealthX Big Pharma and/or more NIAID PARTNERSHIP(s)
9. Deramiocel US earnings in 2026
10. More Analysts
11. Quarterly Report updates
12. Increased Share Price Targets by Analysts
Followed by increased chatter about buyout !

Meanwhile Capricor is cash rich with some $330 million cash; an $80 million NS milestone upon US approval and a PRV worth as much as $200 million ,$605 million sales milestones+ new partnership upfronts and milestones !